About This Video
FendX Technologies Inc. CEO Dr. Carolyn Myers is joined by her team as they open the day's trading session on April 13, 2023 from CSE HQ in Toronto, Canada. FendX Technologies began trading on the Canadian Securities Exchange on March 20, 2023 under the symbol CSE:FNDX
About FendX Technologies
FendX Technologies Inc. is a nanotechnology company focused on developing products that reduce the transmission of pathogens, with a wide range of applications in healthcare and other industries. Their first product under development, REPELWRAP film, is a protective surface coating film that, due to its repelling properties, prevents adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners. The Company has an exclusive world-wide license to its technology, including an IP portfolio.
Read the TranscriptAuto-generated by YouTube; names and terms may be misspelled.
together we will count down to the market open and this will be followed by an interview with the company executive
I'm Carolyn Myers the CEO and co-founder of fendex Technologies Inc which was founded about two and a half years ago and Incorporated in July of 2020. my background is pharmaceutical I've helped very senior level positions within big Pharma companies in the United States and Canada and have a very strong track record in bringing products to Market with Excellence as well as licensing and business development and building companies through a very strong
strategy and vision what do we do at fendex we basically have nanotechnology that has repelling properties that prevent the adhesion of bacteria viruses and liquids to any surface that it's applied to and where this is important is in Infectious Disease Control and that's our that's our focus at fendex so we have a very very experienced team our CFO Rose is an experienced Finance person having held positions in other public companies
Andrea Mulder who has tremendous experience in the operations side of the business and she is the person that essentially has taken our the technology from McMaster for our first product repel rep film to where it is today and US transferring it to our manufacturer for scale up Tash our project manager who makes sure that we do everything and we do it on time and and in a very
responsible way so she's an important member of the team as well and I can't say enough about the lead researchers Leila solimani and tohi dadar who are the creators of this technology and we wouldn't be here today without them so they're an integral part of our team as well our first product is a Repel wrap film that will be applied to surfaces that are prone to contamination High
contamination by pathogens so what it in essence does is it prevents the transmission of those bugs or pathogens and our first product as I said repel rep film is in the process of being trans transitioned from McMasters lab start the actual scale of this product with the idea of assessing the scalability of it we're exploring more opportunities one of them as as an example is coding catheters and we're in
a very early stage of developing catheters that are coated with this technology but the whole idea behind it is to prevent blood clotting and bacterial biofilm formation within the catheters which are are culprits in terms of catheter occlusion so we're very excited about that opportunity too so we listed on the CSC given number one the size of our cup company given the strengths of the CSE the support we
expect from the CSC and you know it's just it was the right exchange for us we've seen a lot of success with the CSC and we anticipate our company as part of the CSC will be will be beneficial for both of us so we're really excited to be a part of the CSC and trading today
thank you
More CSE Market Open
Ring the Bell for Financial Literacy 2026Oct 8, 2026

